IP Library Granted Patent US 7,968,614
Granted Patent B2
US 7,968,614 · App. 11/453,494 · Granted Jun 28, 2011

Macromer composition including light activated initiator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,614
App. No.
11/453,494
Granted
Jun 28, 2011
Kind
B2
Abstract

The invention provides compositions that include macromers and visible light-activated polymerization initiators, and methods for forming a matrix using these compositions in conjunction with a light source that emits light primarily in the visible light spectrum.

Claims (21)

1. A method for forming a matrix in situ in a periodontal procedure, comprising the steps of (a) applying a matrix-forming periodontal composition to a tissue in the oral cavity, the composition comprising (i) a macromer comprising a polysaccharide and (ii) a water-soluble diketone photoinitiator having an activation wavelength of 400 nm or greater; and (b) treating the composition to activate the diketone photoinitiator and promote formation of a matrix.

2. The method of claim 1 wherein the diketone photoinitiator has an activation wavelength in the range of 440 nm to 500 mm.

3. The method of claim 2 wherein the diketone photoinitiator is water-soluble camphorquinone.

4. The method of claim 1 wherein the macromer comprises hyaluronic acid.

5. The method of claim 1 wherein the macromer is present at a concentration in the range of 50 mg/mL to 100 mg/mL.

6. The method of claim 1 wherein the composition has a viscosity of about 500 cP or greater.

7. The method of claim 1 wherein the composition comprises a peroxide or hydroperoxide co-initiator.

8. The method of claim 1 wherein the composition comprises an alkyl hydroperoxide co-initiator.

9. The method of claim 7 wherein the co-initiator is present at a concentration of 7 mg/mL or greater.

10. The method of claim 1 wherein step (b) comprises activating the diketone photoinitiator with a visible-light emitting source selected from the group consisting of plasma arc sources, conventional halogen lamps, fast halogen lamps, and LEDs.

11. The method of claim 1 wherein the composition comprises a bioactive agent.

12. The method of claim 11 wherein the bioactive agent comprises a bioactive peptide.

13. The method of claim 12 , wherein the bioactive peptide comprises a bioactive collagen peptide.

14. The method of claim 1 , wherein the composition comprises filler particles.

15. The method of claim 1 , wherein the composition does not include a tertiary amine co-initiator.

16. The method of claim 1 , wherein the macromer has a molecular weight of 1×10 5 Da or greater.

17. A polymerizable composition for in situ use comprising a macromer, comprising a polysaccharide and a water-soluble diketone polymerization photoinitiator having an activation wavelength of greater than 400 nm, wherein the composition has a viscosity of 500 cP or greater.

18. A method for providing a matrix in situ comprising the steps of (a) providing a matrix-forming composition to a surface, the composition including a (i) macromer comprising a polysaccharide and (ii) a water soluble visible light activated diketone photoinitiator, and (b) activating the photoinitiator to promote formation of the matrix with a LED source having a peak emission wavelength of greater than 400 nm.

19. The method of claim 1 wherein the diketone photoinitiator comprises a charged group.

20. The method of claim 3 wherein the diketone photoinitiator is camphorquinone-10-sulfonic acid.

21. The polymerizable composition of claim 17 wherein the diketone photoinitiator is camphorquinone-10-sulfonic acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS, INC.
To: SURMODICS MD, LLC
Reel/Frame 073894/0058 →